Precision medicine is key to developing more effective and less toxic treatments, representing the present and future of oncology research. This approach offers significant promise for incremental ...
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center Of the 582 surveys sent, ...
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics (BNGO), Inc. , today announced the publication in Cancers of a peer-reviewed study from Augusta University on the utility of combining ...
Leading genomics solutions provider debuts complete NGS library preparation to support the identification of novel monkeypox variants in response to growing researcher demands for viral surveillance ...
GUILDFORD, SURREY / ACCESSWIRE / September 23, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...
A joint model combining decision tree with partitioned survival models was developed. A two-round consensus panel was performed to describe clinical practice of Spanish reference centers, providing ...
Pillar's research-use-only (RUO) oncoReveal ® Essential MPN, a rapid 3-gene NGS panel designed to quickly streamline the evaluation of myeloproliferative neoplasms (MPN) through the interrogation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results